Performing Department
AGNR-Animal & Avian Sciences
Non Technical Summary
The Swine in Biomedical Research Conference 2016 will highlight the growing utility of swine models in biomedical research. In the toolbox category, the transformational nature of meganucleases such as Tal effector nucleases and CRISPR-cas are just beginning to be appreciated, and will allow the generation of relevant swine models for use in agriculture and biomedical research. These models will have impact on human and animal health, reproduction, and nutrition. Similarly, advances in cellular reprogramming of somatic cells into pluripotent cells continues to advance at a rapid pace and will provide novel applications in both agriculture, and human and animal health. In the applications category, there is still much to explore in immunology, nutrition, transplantation, cardiovascular disease, and orthopedics. New initiatives are also warranted in zoonotic diseases, bioengineering and regenerative medicine. This conference will provide an excellent platform for discussion of these models. Recent workshops have focused on utilizing animal sciences expertise traditionally supported by the USDA in support of NIH funded investigators that utilize pig models. The joint USDA and NIH discussions identified cultural differences and a lack of in-depth knowledge of needs and opportunities as major rate limiting issues. Hence, this conference has been organized to directly address these acknowledged limitations.
Animal Health Component
25%
Research Effort Categories
Basic
50%
Applied
25%
Developmental
25%
Goals / Objectives
This proposal is in response to FY 2015 Foundational Animal Reproduction A1211 request for applications. The conference is to be held at the Loews Annapolis Hotel, in Annapolis, MD from 06/05/2016-06/07/2016. The Swine in Biomedical Research Conference 2016 will highlight the growing utility of swine models in biomedical research. In the toolbox category, the transformational nature of meganucleases such as Tal effector nucleases and CRISPR-cas are just beginning to be appreciated, and will allow the generation of relevant swine models for use in agriculture and biomedical research. These models will have impact on human and animal health, reproduction, and nutrition. Similarly, advances in cellular reprogramming of somatic cells into pluripotent cells continues to advance at a rapid pace and will provide novel applications in both agriculture, and human and animal health. In the applications category, there is still much to explore in immunology, nutrition, transplantation, cardiovascular disease, and orthopedics. New initiatives are also warranted in zoonotic diseases, bioengineering and regenerative medicine. This conference will provide an excellent platform for discussion of these models. Recent workshops have focused on utilizing animal sciences expertise traditionally supported by the USDA in support of NIH funded investigators that utilize pig models. The joint USDA and NIH discussions identified cultural differences and a lack of in-depth knowledge of needs and opportunities as major rate limiting issues. Hence, this conference has been organized to directly address these acknowledged limitations.
Project Methods
In order to achieve the defined outcomes and deliverables, the conference has been organized to provide significant discussion among the participants. Each of the sessions will have invited speakers selected with respect to their individual expertise and who will provide a summary of the topic or identify opportunities and needs. Poster sessions will provide additional opportunities to showcase existing models, methodologies and experimental approaches. Session Chairs will be responsible for leading discussion towards defined deliverables, ensuring that existing resources are adequately recognized and to assess priorities within the community. Each poster session will have a Moderator (selected from participants to provide diversity representation) who will be responsible for selecting oral presentations from the submitted abstracts. The planned Poster Sessions are: (1) Immunology and Infectious Diseases; 2) Nutrition (Obesity and Diabetes; (3) Genomics; (4) Physiology; (5) Transgenesis and Cloning; (6) Bioengineering and Regenerative Medicine; (7) Transplantation (allo and xeno); (8) Cardiovascular; (9) Cancer; (10) Drug development (Pharmaceutical); and (11) Clinical Models (applications and regulations).